- Latest news▼
-
18:28, May 2 Sixth Armenian International Ophthalmological Conference will be held on 17-19 May
-
16:11, May 2 ВJN: High-fat foods may increase the risk of heart attack and stroke at a young age
-
14:16, May 2 Patterns: Neural network created that models outcome of various patient therapy methods
-
12:05, May 2 Armenia joins Council of Europe convention on protection of patients' rights
-
14:27, May 1 Journal of Neuroscience: Sluggishness of the elderly is due to greater use of calories, research finds
-
10:26, May 1 AstraZeneca admits its Covid vaccine can cause thrombosis
-
19:31, April 30 Scientists calculated how much time per day you should be sitting, standing and sleeping
-
17:37, April 30 The Conversation: Keeping bread in the fridge improves its health benefits
-
14:30, April 30 Frontiers in Molecular Biosciences: Researchers use AI to identify 191 new destructive viruses
-
08:38, April 30 The Guardian: First personalized cancer vaccine developed
-
23:55, April 29 Ketodiet improved the condition of patients with schizophrenia and bipolar disorder
-
19:47, April 29 In 64% of COVID-19 survivors, the condition worsens after one year
-
15:41, April 29 ECU: body tilt in patients after stroke was found to be curable
-
13:37, April 29 Blood: blood cancer drugs may be useful in rheumatoid arthritis
-
13:15, April 29 362 cases of measles recorded in Armenia so far in 2024
All materials
WHO stops research on hydroxychloroquine for COVID-19 treatment
The World Health Organization once again halted research on hydroxychloroquine for the COVID-19 treatment, Reuters reported.
WHO expert Ana Maria Henao-Restrepo noted: "After deliberation, they have concluded that the hydroxychloroquine arm will be stopped from the Solidarity Trial."
According to medportal.ru, back in March, WHO announced the start of a major study (Solidarity) of several drugs to combat COVID-19. Hydroxychloroquine was among the tested drugs. However, at the end of May, a large study published in The Lancet showed that this drug was ineffective against coronavirus. This study was subsequently withdrawn, but the WHO managed to suspend the study of chloroquine and hydroxychloroquine.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- ESCMID: New method of purifying the air with ultraviolet light could protect world from new pandemic 1451
- Children’s Hospital Los Angeles and International Center of Professional Development Allergy/Immunology Conference 1344
- Enzymes that convert different blood groups into first group are discovered 1308
- 3 women diagnosed with HIV for first time after getting ‘beauty injections’ in US 1146
- 362 cases of measles recorded in Armenia so far in 2024 835
- In 64% of COVID-19 survivors, the condition worsens after one year 805
- Ketodiet improved the condition of patients with schizophrenia and bipolar disorder 778
- ECU: body tilt in patients after stroke was found to be curable 764
- Blood: blood cancer drugs may be useful in rheumatoid arthritis 749
- Scientists calculated how much time per day you should be sitting, standing and sleeping 642
- The Guardian: First personalized cancer vaccine developed 641
- Frontiers in Molecular Biosciences: Researchers use AI to identify 191 new destructive viruses 607
- The Conversation: Keeping bread in the fridge improves its health benefits 605
- AstraZeneca admits its Covid vaccine can cause thrombosis 529
- Journal of Neuroscience: Sluggishness of the elderly is due to greater use of calories, research finds 434
- Find us on Facebook
- Poll